Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biol Cell ; 32(20): ar10, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34379441

ABSTRACT

Mutations in the genes that encode α- and ß-tubulin underlie many neurological diseases, most notably malformations in cortical development. In addition to revealing the molecular basis for disease etiology, studying such mutations can provide insight into microtubule function and the role of the large family of microtubule effectors. In this study, we use budding yeast to model one such mutation-Gly436Arg in α-tubulin, which is causative of malformations in cortical development-in order to understand how it impacts microtubule function in a simple eukaryotic system. Using a combination of in vitro and in vivo methodologies, including live cell imaging and electron tomography, we find that the mutant tubulin is incorporated into microtubules, causes a shift in α-tubulin isotype usage, and dramatically enhances dynein activity, which leads to spindle-positioning defects. We find that the basis for the latter phenotype is an impaired interaction between She1-a dynein inhibitor-and the mutant microtubules. In addition to revealing the natural balance of α-tubulin isotype utilization in cells, our results provide evidence of an impaired interaction between microtubules and a dynein regulator as a consequence of a tubulin mutation and sheds light on a mechanism that may be causative of neurodevelopmental diseases.


Subject(s)
Dyneins/metabolism , Microtubule-Associated Proteins/metabolism , Saccharomyces cerevisiae Proteins/genetics , Tubulin/genetics , Dyneins/genetics , Electron Microscope Tomography/methods , Lectins, C-Type/genetics , Lectins, C-Type/metabolism , Microtubules/metabolism , Mutation , Neurodevelopmental Disorders/metabolism , Neurogenesis , Phenotype , Receptors, Mitogen/genetics , Receptors, Mitogen/metabolism , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomycetales/metabolism , Spindle Apparatus/metabolism , Tubulin/metabolism
2.
Development ; 126(10): 2093-102, 1999 May.
Article in English | MEDLINE | ID: mdl-10207135

ABSTRACT

Vascular endothelial (VE)-cadherin is an adhesive transmembrane protein specifically expressed at interendothelial junctions. Its extracellular domain exhibits Ca2+-dependent homophilic reactivity, promoting cell-cell recognition. Mice deficient in VE-cadherin die at mid-gestation resulting from severe vascular defects. At the early phases of vascular development (E8.5) of VE-cadherin-deficient embryos, in situ differentiation of endothelial cells was delayed although their differentiation program appeared normal. Vascularization was defective in the anterior part of the embryo, while dorsal aortae and vitelline and umbilical arteries formed normally in the caudal part. At E9.25, organization of endothelial cells into large vessels was incomplete and angiogenesis was impaired in mutant embryos. Defects were more severe in extraembryonic vasculature. Blood islands of the yolk sac and clusters of angioblasts in allantois failed to establish a capillary plexus and remained isolated. This was not due to defective cell-cell recognition as endothelial cells formed intercellular junctions, as shown by electron microscopy. These data indicate that VE-cadherin is dispensable for endothelial homophilic adhesion but is required for vascular morphogenesis.


Subject(s)
Cadherins/physiology , Endothelium, Vascular/physiology , Neovascularization, Physiologic/physiology , Animals , Antigens, CD , Cadherins/genetics , Embryonic and Fetal Development , Hematopoiesis , Mice , Morphogenesis , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL
...